drugset / Trial / NCT06351566

Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

NCT06351566

RandomizedFactorialQuadruple-blindPrevention

Summary

The goal of this randomized, double-blind, placebo-controlled, 6-month supplementation study in individuals with type 2 diabetes is to investigate whether taking daily dietary supplements of vitamin D3 (1600 IU) or prebiotics (inulin, 10 gram) has beneficial effects on cardiovascular disease risk factors.

Timeline

Start
2024-04-25
Primary completion
2024-12-31
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 1600 iu